
Chemotherapy
Systemic treatment plans selected according to diagnosis, stage, treatment intent and the patient’s overall condition, with monitoring for response and side effects.
Treatment selection depends on cancer type, stage, biomarkers, prior therapy, overall health and treatment goals. Not every treatment is appropriate for every patient.

Systemic treatment plans selected according to diagnosis, stage, treatment intent and the patient’s overall condition, with monitoring for response and side effects.

Treatment that helps the immune system recognise and attack cancer cells, used for selected cancers when clinical and biomarker criteria support it.

Precision medicines directed at specific molecular pathways or abnormalities that help certain cancer cells grow and survive.

Treatment for selected hormone-sensitive cancers, including many breast and prostate cancers, depending on receptor and disease characteristics.

Use of molecular, genetic or biomarker information to refine treatment selection where such testing is clinically relevant.

Risk assessment and appropriate screening can help detect selected cancers earlier, when evaluation and treatment options may differ.

Symptom control, side-effect management and quality-of-life support can be integrated alongside active cancer treatment.